Literature DB >> 10722638

Specificity of human antibodies reactive with pneumococcal C polysaccharide.

C E Frasch1, N F Concepcion.   

Abstract

Antibodies reactive with C polysaccharide (PS) were found in healthy adults, pneumococcal patients, and vaccinees. These antibodies were not directed to the phosphocholine determinant of the C PS, as they appear to be in mice, since the human antibodies were inhibitable only with C PS. We found another population of phosphocholine-specific antibodies inhibitable only by phosphocholine and related compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722638      PMCID: PMC97422          DOI: 10.1128/IAI.68.4.2333-2337.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  The chemical composition of pneumococcal C-polysaccharide.

Authors:  T Y LIU; E C GOTSCHLICH
Journal:  J Biol Chem       Date:  1963-06       Impact factor: 5.157

2.  Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection?

Authors:  D M Musher; D A Watson; R E Baughn
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

3.  Heterogeneity of the human phosphocholine-specific B cell repertoire.

Authors:  L D Stein; N H Sigal
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

4.  Subpopulations of antibodies to phosphocholine in human serum.

Authors:  M Brown; G Schiffman; M B Rittenberg
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

5.  The pneumococcal common antigen C-polysaccharide occurs in different forms. Mono-substituted or di-substituted with phosphocholine.

Authors:  C Karlsson; P E Jansson; U B Skov Sørensen
Journal:  Eur J Biochem       Date:  1999-11

6.  Epidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine.

Authors:  B M Gray; H C Dillon; D E Briles
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

7.  Teichoic acid and lipoteichoic acid of Streptococcus pneumoniae possess identical chain structures. A reinvestigation of teichoid acid (C polysaccharide).

Authors:  W Fischer; T Behr; R Hartmann; J Peter-Katalinić; H Egge
Journal:  Eur J Biochem       Date:  1993-08-01

8.  Anti-C-carbohydrate antibodies after pneumococcal vaccination.

Authors:  F K Pedersen; J Henrichsen; U S Sørensen; J L Nielsen
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1982-12

9.  Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae.

Authors:  G Vitharsson; I Jónsdóttir; S Jónsson; H Valdimarsson
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

10.  Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides.

Authors:  D E Briles; G Scott; B Gray; M J Crain; M Blaese; M Nahm; V Scott; P Haber
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

View more
  4 in total

Review 1.  Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

Authors:  Catherine M Wernette; Carl E Frasch; Dace Madore; George Carlone; David Goldblatt; Brian Plikaytis; William Benjamin; Sally A Quataert; Steve Hildreth; Daniel J Sikkema; Helena Käyhty; Ingileif Jonsdottir; Moon H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.

Authors:  N F Concepcion; C E Frasch
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

3.  IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigens.

Authors:  Paul J Maglione; Noa Simchoni; Samuel Black; Lin Radigan; Jessica R Overbey; Emilia Bagiella; James B Bussel; Xavier Bossuyt; Jean-Laurent Casanova; Isabelle Meyts; Andrea Cerutti; Capucine Picard; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2014-10-15       Impact factor: 22.113

4.  The Influence of a Conjugated Pneumococcal Vaccination on Plasma Antibody Levels against Oxidized Low-Density Lipoprotein in Metabolic Disease Patients: A Single-Arm Pilot Clinical Trial.

Authors:  Ronit Shiri-Sverdlov; Inês Magro Dos Reis; Yvonne Oligschlaeger; Tim Hendrikx; Dennis M Meesters; Annick Vanclooster; Nele Vanhoutvin; Ger H Koek; Marit Westerterp; Christoph J Binder; David Cassiman; Tom Houben
Journal:  Antioxidants (Basel)       Date:  2021-01-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.